Interaction of ACE inhibitors and aspirin in patients with congestive heart failure

Annals of Pharmacotherapy

Volumn 33, Issue 3, 1999, Pages 375-377

  Song, Karen H ^a   Fedyk, Renee ^b   Hoover, Rhonda ^c  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c Bldg 115/5Th Fl ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG RESEARCH; HUMAN; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CLINICAL TRIALS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0032925789     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18129     Document Type: Article

References (20)

1. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. N Engl J Med 1972;287:781-7.
2. Parmley WW. Pathophysiology of congestive heart failure. Am J Cardiol 1985;55:9A-14A.
3. Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ. Captopril induced changes in prostaglandin production. J Clin Invest 1980;65:1257-64.
4. Moore TJ, Crantz FR, Hollenberg NK, Koletsky RJ, Leboff MS, Swartz SL, et al. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 1981;3:168-73.
5. Goldstone R, Martin K, Zisper R, Horton R. Evidence for a dual action of converting enzyme inhibitor on blood pressure in a man. Prostaglandins 1981;22:587-98.
6. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in heart failure: relationship to renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-52.
7. Dzau VJ, Swartz SL, Creager MA. The role of prostaglandins in the pathophysiology of and therapy for congestive heart failure. Heart Failure 1986;2:6-13.
8. Dzau VJ, Swartz SL, Williams GH. Dissociation of renin-angiotensin and prostaglandin systems during captopril therapy in congestive heart failure. J Am Coll Cardiol 1983;1:727-32.
9. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:323-5.
10. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1988;318:262-4.
11. Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991;266:521-7.
12. Coronary Drug Project Group. Aspirin in coronary heart disease. J Chronic Dis 1976;29:625-42.
13. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979;2:1313-5.
14. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396403.
15. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levey G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319:1105-11.
16. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with anti-platelet therapy: results of a Veterans Administration Cooperative Study. Circulation 1988;77:1324-32.
17. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20: 1549-55.
18. Wijngaarden JV, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SAJ, van Veldhuisen DJ, et al. Effects of acetylsalicyclic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994; 23:240-5.
19. Nguyen KN, Aursness I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup Analysis of the Cooperative New Scandinavian Enalapril Survival Study II. Am J Cardiol 1997;79:115-9.
20. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Effect of antiplatelet agents on survival in patients with left ventricular systolic dysfunction (abstract). Circulation 1995;92:1-665.